Global Gene Therapies for Tumor Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Gene Therapies for Tumor Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
Gene Therapies for Tumor Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gene Therapies for Tumor Treatment market is projected to reach US$ 20270 million in 2029, increasing from US$ 4915 million in 2022, with the CAGR of 20.1% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gene Therapies for Tumor Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Novartis
Gilead Sciences
Amgen
Shanghai Sunway
Sibiono
Segment by Type
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gene Therapies for Tumor Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gene Therapies for Tumor Treatment introduction, etc. Gene Therapies for Tumor Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Gene Therapies for Tumor Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Gene Therapies for Tumor Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gene Therapies for Tumor Treatment market is projected to reach US$ 20270 million in 2029, increasing from US$ 4915 million in 2022, with the CAGR of 20.1% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gene Therapies for Tumor Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Novartis
Gilead Sciences
Amgen
Shanghai Sunway
Sibiono
Segment by Type
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Gene Therapies for Tumor Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Gene Therapies for Tumor Treatment introduction, etc. Gene Therapies for Tumor Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Gene Therapies for Tumor Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices